Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 11, 2021 06:50 ET | Source: Pasithea

Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

MIAMI BEACH, Fla., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
September 29, 2021 16:30 ET | Source: Pasithea

Pasithea Therapeutics Corp. to Present at the Benzinga Healthcare Small Cap Conference

MIAMI BEACH, Fla., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
September 17, 2021 16:05 ET | Source: Pasithea

Pasithea Therapeutics Corp. Announces Closing of $24.0 Million Initial Public Offering

MIAMI BEACH, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
September 14, 2021 21:04 ET | Source: Pasithea

Pasithea Therapeutics Corp. Announces Pricing of Upsized $24.0 Million Initial Public Offering

MIAMI BEACH, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. ("Pasithea" or the "Company"), a biotechnology company focused on the research and discovery of new and effective...